Pulmonary Hypertension

Authors: Abel P Wakai / Editor: Jason M Kendall / Reviewer: Stewart McMorran, Eugene Henry / Code: A1 / Published: 30/07/2021

Description:

Patients with known pulmonary hypertension may present to the emergency department with a variety of acute problems related to this disease such as pulmonary embolism, acute right heart failure, cardiac arrest, catheter-related sepsis and technical problems with intravenous catheters. In patients with previously undiagnosed pulmonary hypertension, the emergency physician is in a strong position to consider the initial diagnosis as long as there is a high index of suspicion in any patient presenting with breathlessness in the absence of an alternative cause of cardiorespiratory disease.

After completing this session you will be able to:

  • Define pulmonary hypertension
  • Identify the clinical conditions associated with pulmonary hypertension
  • Recognise the pathophysiology of pulmonary hypertension and related right heart failure
  • Know when to suspect the presence of pulmonary hypertension
  • Recognise the problems associated with pulmonary hypertension that may present to the emergency department
  • Identify current management options for pulmonary hypertension

References:

  1. Rubin LJ, Badesch DB. Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med. 2005 Aug 16;143(4):282-92.
  2. Rubin LJ; American College of Chest Physicians. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul;126(1 Suppl):7S-10S.
  3. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997 Jan 9;336(2):111-7.
  4. Humbert M. Update in pulmonary arterial hypertension 2007. Am J Respir Crit Care Med. 2008 Mar 15;177(6):574-9.
  5. Humbert M, Khaltaev N, Bousquet J, Souza R. Pulmonary hypertension: from an orphan disease to a public health problem. Chest. 2007 Aug;132(2):365-7.
  6. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S-12S.
  7. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30.
  8. Peacock A, Murphy NF, McMurray JJV, et al. An epidemiological study of pulmonary arterial hypertension in Scotland. Eur Respir J 2007;30:104-109.
  9. Hoeper MM, Rubin LJ. Update in Pulmonary Hypertension 2005. Am J Respir Crit Care Med 2006;173:499-505.
  10. Rich S. Primary pulmonary hypertension: executive summary from the World Symposium on Primary Pulmonary Hypertension. Evian, France: World Health Organization; 1998.
  11. Edelman JD. Clinical presentation, differential diagnosis, and vasodilator testing of pulmonary hypertension. Semin Cardiothorac Vasc Anesth. 2007 Jun;11(2):110-8.
  12. Ahearn GS, Tapson VF, Rebeiz A, et al. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 2002;122:524-527.
  13. Sandoval J, Aguirre JS, Pulido T, et al. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1682-7.
  14. Acosta F, Sansano T, Palenciano CG, et al. Effects of dobutamine on right ventricular function and pulmonary circulation in pulmonary hypertension during liver transplantation. Transplant Proc 2005;37:3869-3870.
  15. Hirsch LJ, Rooney MW, Wat SS, et al. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest. 1991 Sep;100(3):796-801.
  16. Leather HA, Segers P, Berends N, et al. Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 2002;30:2548-2552.
  17. Rich S, Gubin S, Hart K. The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. Chest. 1990 Nov;98(5):1102-6.
  18. Rothman A, Sklansky MS, Lucas VW, et al. Atrial septostomy as a bridge to   lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol 1999;84:682-686.
  19. National Pulmonary Hypertension Centres of the UK and Ireland. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Thorax 2008;63 Suppl 2:ii1-ii41.
  20. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology and the European Respiratory Society. European Heart Journal, vol. 37, issue 1, 1 Jan 2016, pages 67-119.
  21. Simonneau G, Hoeper MM. The revised definition of pulmonary hypertension: exploring the impact on patient management. European Heart Journal Supplements. 2019; 21(Supplement_K):K4-K8.
  22. Connolly MJ, Kovacs G. Pulmonary hypertension: a guide for GPs. Br J Gen Pract. 2012;62(604):e795-e7.

Leave a Reply